SEGMENT INFORMATION (Tables)

3 Months Ended

Mar. 31, 2026

Segment Reporting [Abstract]

SCHEDULE OF SEGMENT REVENUE

The CODM examines, within each operational function, the employee salaries including the bonus and share based compensation. In addition, the CODM examines the clinical trials expenses within the research and development operations.

	Three months ended March 31,
	2026			2025
Revenues		3,398			1,529
Cost of Revenues:
Material and Labor		1,691			1,025
Other cost of revenues		1,020			212
Total Cost of Revenues		2,711			1,237
Research and development (R&D)
Payroll and Benefits		1,600			855
Share based compensation		175			668
Clinical trials		1,459			1,160
Other R&D		1,529			1,376
Total Research and development		4,763			4,059
Selling and marketing (S&M)
Payroll and Benefits		3,863			1,979
Share based compensation		581			217
Other S&M		736			554
Total Selling and marketing		5,180			2,750
General and administrative (G&A)
Payroll and Benefits		1,807			1,676
Share based compensation		1,289			1,779
Other G&A		1,626			1,488
Total General and administrative		4,722			4,943
Financial Income, net;		289			294
Segment net Loss		(13,689	)		(11,166	)